NO981537L - FremgangsmÕte for fremstilling av antimalariamedikamenter - Google Patents
FremgangsmÕte for fremstilling av antimalariamedikamenterInfo
- Publication number
- NO981537L NO981537L NO981537A NO981537A NO981537L NO 981537 L NO981537 L NO 981537L NO 981537 A NO981537 A NO 981537A NO 981537 A NO981537 A NO 981537A NO 981537 L NO981537 L NO 981537L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- antimalarial drugs
- antimalarial
- drugs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/40—Nitrogen atoms attached in position 8
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Quinoline Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9521004.3A GB9521004D0 (en) | 1995-10-13 | 1995-10-13 | Process |
PCT/EP1996/004433 WO1997013753A1 (en) | 1995-10-13 | 1996-10-11 | Process for the preparation of anti-malarial drugs |
Publications (3)
Publication Number | Publication Date |
---|---|
NO981537L true NO981537L (no) | 1998-04-03 |
NO981537D0 NO981537D0 (no) | 1998-04-03 |
NO313285B1 NO313285B1 (no) | 2002-09-09 |
Family
ID=10782264
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19981537A NO313285B1 (no) | 1995-10-13 | 1998-04-03 | Fremgangsmåte for fremstilling av forbindelser som er nyttige for antimalariamedikamenter, samt mellomprodukter forfremgangsmåten |
Country Status (28)
Country | Link |
---|---|
US (1) | US6479660B1 (no) |
EP (1) | EP0871616B1 (no) |
JP (1) | JP4083803B2 (no) |
KR (1) | KR100453256B1 (no) |
CN (1) | CN1147475C (no) |
AR (1) | AR004015A1 (no) |
AT (1) | ATE214372T1 (no) |
AU (1) | AU709333B2 (no) |
BR (1) | BR9611010A (no) |
CA (1) | CA2231633C (no) |
CZ (1) | CZ290380B6 (no) |
DE (1) | DE69619863T2 (no) |
DK (1) | DK0871616T3 (no) |
ES (1) | ES2170874T3 (no) |
GB (1) | GB9521004D0 (no) |
HK (1) | HK1016180A1 (no) |
HU (1) | HUP9900739A3 (no) |
IL (1) | IL124060A (no) |
NO (1) | NO313285B1 (no) |
NZ (1) | NZ320209A (no) |
PL (1) | PL186055B1 (no) |
PT (1) | PT871616E (no) |
SA (1) | SA97170574B1 (no) |
SI (1) | SI0871616T1 (no) |
TR (1) | TR199800637T2 (no) |
TW (1) | TW450950B (no) |
WO (1) | WO1997013753A1 (no) |
ZA (1) | ZA968550B (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08276712A (ja) * | 1995-04-05 | 1996-10-22 | Masao Tsuji | チュ−ブレススパイクタイヤ |
GB0210150D0 (en) | 2002-05-03 | 2002-06-12 | Smithkline Beecham Plc | Process |
JP2009507824A (ja) * | 2005-09-12 | 2009-02-26 | カウンシル・オブ・サイエンティフィック・アンド・インダストリアル・リサーチ | 抗マラリアベイリス−ヒルマン付加物およびその調製方法 |
WO2007127930A2 (en) * | 2006-04-28 | 2007-11-08 | Kansas State University Research Foundation | Compounds affecting gap junction activity |
GB0620005D0 (en) | 2006-10-10 | 2006-11-22 | Glaxo Group Ltd | Compounds |
US20090076072A1 (en) * | 2007-09-14 | 2009-03-19 | Protia, Llc | Deuterium-enriched tafenoquine |
ES2453206B1 (es) | 2013-09-25 | 2015-01-12 | Thyssenkrupp Elevator Innovation Center, S.A. | Sistema de tracción para un sistema de transporte |
CN113248431A (zh) * | 2021-05-21 | 2021-08-13 | 重庆医药高等专科学校 | 一种磷酸伯氨喹的制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4431807A (en) * | 1980-06-12 | 1984-02-14 | The United States Of America As Represented By The Secretary Of The Army | 4-Methyl-5-(unsubstituted and substituted phenoxy)-6-methoxy-8-(aminoalkylamino)quinolines |
US4617394A (en) | 1985-10-15 | 1986-10-14 | The United States Of America As Represented By The Secretary Of The Army | 4-methyl-5-(unsubstituted and substituted phenoxy)-2,6-dimethoxy-8-(aminoalkylamino) quinolines |
-
1995
- 1995-10-13 GB GBGB9521004.3A patent/GB9521004D0/en active Pending
-
1996
- 1996-10-10 ZA ZA9608550A patent/ZA968550B/xx unknown
- 1996-10-11 IL IL12406096A patent/IL124060A/xx not_active IP Right Cessation
- 1996-10-11 PL PL96326194A patent/PL186055B1/pl not_active IP Right Cessation
- 1996-10-11 WO PCT/EP1996/004433 patent/WO1997013753A1/en active IP Right Grant
- 1996-10-11 SI SI9630461T patent/SI0871616T1/xx unknown
- 1996-10-11 ES ES96934646T patent/ES2170874T3/es not_active Expired - Lifetime
- 1996-10-11 KR KR10-1998-0702696A patent/KR100453256B1/ko not_active IP Right Cessation
- 1996-10-11 DK DK96934646T patent/DK0871616T3/da active
- 1996-10-11 DE DE69619863T patent/DE69619863T2/de not_active Expired - Lifetime
- 1996-10-11 AU AU72910/96A patent/AU709333B2/en not_active Ceased
- 1996-10-11 AT AT96934646T patent/ATE214372T1/de not_active IP Right Cessation
- 1996-10-11 TR TR1998/00637T patent/TR199800637T2/xx unknown
- 1996-10-11 JP JP51471997A patent/JP4083803B2/ja not_active Expired - Fee Related
- 1996-10-11 US US09/051,571 patent/US6479660B1/en not_active Expired - Fee Related
- 1996-10-11 AR ARP960104723A patent/AR004015A1/es active IP Right Grant
- 1996-10-11 BR BR9611010A patent/BR9611010A/pt not_active Application Discontinuation
- 1996-10-11 CA CA002231633A patent/CA2231633C/en not_active Expired - Fee Related
- 1996-10-11 EP EP96934646A patent/EP0871616B1/en not_active Expired - Lifetime
- 1996-10-11 HU HU9900739A patent/HUP9900739A3/hu unknown
- 1996-10-11 PT PT96934646T patent/PT871616E/pt unknown
- 1996-10-11 NZ NZ320209A patent/NZ320209A/xx not_active IP Right Cessation
- 1996-10-11 CZ CZ19981103A patent/CZ290380B6/cs not_active IP Right Cessation
- 1996-10-11 CN CNB961975644A patent/CN1147475C/zh not_active Expired - Fee Related
- 1996-10-14 TW TW085112489A patent/TW450950B/zh active
-
1997
- 1997-01-20 SA SA97170574A patent/SA97170574B1/ar unknown
-
1998
- 1998-04-03 NO NO19981537A patent/NO313285B1/no not_active IP Right Cessation
-
1999
- 1999-04-07 HK HK99101378A patent/HK1016180A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO974557D0 (no) | Fremgangsmåte for fremstilling av respirerbare partikler | |
NO973938D0 (no) | Farmasöytisk preparat av piperdinoalkanolforbindelser | |
NO961006D0 (no) | Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene | |
NO981800L (no) | FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan | |
TR199600857A2 (tr) | Nikotinamidin hazirlanmasi icin islem. | |
NO982237L (no) | FremgangsmÕte for fremstilling av fenylimidazolidinderivater | |
NO981537D0 (no) | Fremgangsmåte for fremstilling av antimalariamedikamenter | |
FI964229A (fi) | Menetelmä doksorubisiinin valmistamiseksi | |
NO304110B1 (no) | FremgangsmÕte for fremstilling av glutardialdehyd | |
NO963432D0 (no) | Fremgangsmåte for fremstilling av dimetyldiklorsilan | |
NO20003393L (no) | FremgangsmÕte for fremstilling av en farmasøytisk formulering | |
NO980384L (no) | Fremgangsmåte for fremstilling av fastdoseformer av svært lav-dose legemidler | |
NO981798D0 (no) | FremgangsmÕte for fremstilling av faste legemiddelformer | |
NO973835D0 (no) | Fremgangsmåte for fremstilling av lorakarbefmonohydrat | |
NO974747D0 (no) | Fremgangsmåte for fremstilling av streptograminer | |
FI974002A0 (fi) | Menetelmä ranitidiinihydrokloridi 1 muodon valmistamiseksi | |
NO962809D0 (no) | Fremgangsmåte for fremstilling av N-substituerte 4-ketoprolinderivater | |
NO964519D0 (no) | Fremgangsmåte for fremstilling av chitosanalkylderivater | |
NO972129D0 (no) | Fremgangsmåte for fremstilling av 1-halo-3-trialkylsilanyl-benzenderivater | |
NO20003077D0 (no) | FremgangsmÕte for fremstilling av klorbenzooksazolen | |
NO961004L (no) | Fremgangsmåte for fremstilling av N-acetyl-D-glukosamin-deacetylase | |
NO994557D0 (no) | Fremgangsmaate for fremstilling av arylaminotriazolopyridiner | |
FI960790A (fi) | Menetelmä fluoreenibisfenolin valmistamiseksi | |
NO963174D0 (no) | Fremgangsmåte for fremstilling av isovanillin | |
NO20002476D0 (no) | FremgangsmÕte for fremstilling av formylimidazoler |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |